Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Dyadic International is a biotechnology business based in the US. Dyadic International shares (DYAI) are listed on the NASDAQ and all prices are listed in US Dollars. Dyadic International employs 7 staff and has a trailing 12-month revenue of around $2.5 million.
Finder Award
eToro
Finder Award
SoFi Invest
| Latest market close | $1.70 |
|---|---|
| 52-week range | $1.12 - $4.28 |
| 50-day moving average | $1.53 |
| 200-day moving average | $2.24 |
| Wall St. target price | $7.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.44 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.6999 from 2023-01-24
| 1 week (2023-01-19) | 14.86% |
|---|---|
| 1 month (2022-12-23) | 24.08% |
| 3 months (2022-10-26) | -20.93% |
| 6 months (2022-07-26) | -39.72% |
| 1 year (2022-01-22) | N/A |
|---|---|
| 2 years (2021-01-26) | -69.91% |
| 3 years (2020-01-24) | 5.22 |
| 5 years (2018-01-26) | 20.56% |
| Revenue TTM | $2.5 million |
|---|---|
| Gross profit TTM | $459,393 |
| Return on assets TTM | -38.69% |
| Return on equity TTM | -68.4% |
| Profit margin | 0% |
| Book value | $0.44 |
| Market capitalisation | $44.8 million |
TTM: trailing 12 months
We're not expecting Dyadic International to pay a dividend over the next 12 months.
Over the last 12 months, Dyadic International's shares have ranged in value from as little as $1.12 up to $4.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dyadic International's is 0.4527. This would suggest that Dyadic International's shares are less volatile than average (for this exchange).
Dyadic International, Inc. , a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd. ; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S. L.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
